Transcatheter Heart Valve Replacement Market Rising in United States | Fortune Business Insights
The global Transcatheter Heart Valve Replacement market size is anticipated to reach USD 10.34 billion by 2026 on account of the increasing number of death cases caused due to cardiac medical conditions worldwide. THVR is a minimally invasive procedure for replacing a narrowed aortic valve which fails to function properly. Most of the THVR products are currently in their investigational stage. Fortune Business Insights™ offers a comprehensive overview of the market in their recent report titled, “Transcatheter Heart Valve Replacement (THVR) Market Size, Share & Industry Analysis, By Product Type (Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Replacement (TMVR), and Transcatheter Pulmonary Valve Replacement(TPVR)), By End User (Hospitals, and Specialty Clinics& Others), and Regional Forecast, 2019-2026.”According to this report, the market value stood at USD 4.04 billion in 2018 and is expected to rise at a CAGR of 12.5% during the forecast period set between 2019 to 2026.
Get Sample PDF Brochure:
Canada Hosts Launch of Venus Medtech for
Pulmonary Valve Implant
Chinese company for
heart valve, namely Venus Medtech, launched their self-expanding pulmonary
valve implant called Venus P-Valve in Canada in June 2018. This valve is
specially designed for patients who do not prefer cardiopulmonary or sternotomy
bypass surgery as part of the traditional valve replacement surgeries. A simple
delivery system can perform this surgery wherein the valve is inserted percutaneously
on patients who opt out of cardiopulmonary and sternotomy bypass surgeries.
Dr. Ronald Carere
of St. Paul’s Hospital in Canada says, “The success rate of these stents is
highly positive, and we expect it to expand all over the nation. This will replace
the traditional valve replacement surgeries in the coming years.” The company
further planned to launch an FDA clinical trial in 2019. Such innovation is
likely to bode well for the market in the forecast period.
Government-supported Reimbursement Policies
will Help Market Gain Impetus
The increasing
prevalence of cardiovascular diseases among the geriatric and bariatric
population are the major factors promoting the transcatheter heart valve
replacement market growth. Besides this, the advent and increasing popularity
of minimally invasive surgeries are expected to aid in the expansion of the
market. Moreover, improving healthcare infrastructure and medical facilities,
coupled with government-supported reimbursement policies in some regions, are
likely to help the market gain impetus in the coming years.
On the flipside,
established presence and demand for traditional surgical valves especially in
the developing nations may pose a significant threat to the market.
Nevertheless, the rise in the focus of players for the development of Mitral
Valve Products is projected to create lucrative growth opportunities for the
market in the long run.
Speak To Our Analyst:
Related Topics :
About Us:
Fortune Business Insights™ delivers accurate data and innovative
corporate analysis, helping organizations of all sizes make appropriate
decisions. We tailor novel solutions for our clients, assisting them to address
various challenges distinct to their businesses. Our aim is to empower them
with holistic market intelligence, providing a granular overview of the market
they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Comments
Post a Comment